In gastric cancer cells, the proteins glycerol-3-phosphate dehydrogenase 1 (GPD1) and glycerol-3-phosphate dehydrogenase 1-like (GPD1L) drive aberrant lipid droplet accumulation, which subsequently elevates FSP1 expression, enhances resistance to ferroptosis, and promotes peritoneal metastasis [40]. This evidence concerns the gene GPD1L and gastric cancer.